Form FDA 3965 FDA 3965 Tobacco Substantial Equivalence Report Submission

Reports Intended to Demonstrate the Substantial Equivalence of a New Tobacco Product

FDA 3965

Tobacco Substantial Equivalence Report Submission

OMB: 0910-0673

Document [pdf]
Download: pdf | pdf
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

TOBACCO SUBSTANTIAL EQUIVALENCE
REPORT SUBMISSION

Form Approved: OMB No. xxxx-xxxx
Expiration Date: xx/xx/202x
(See Burden Statement on last page.)

FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT
On June 22, 2009, the President signed the Family Smoking Prevention and Tobacco Control Act (Tobacco
Control Act) (Public Law 111-31) into law. The Tobacco Control Act amended the Federal Food, Drug, and
Cosmetic Act (FD&C Act).
STATUTORY REQUIREMENTS
Section 910(a)(1) of the FD&C Act defines a new tobacco product as “(A)any tobacco product (including those
products in test markets) that was not commercially marketed in the United States as of February 15, 2007;
or (B) any modification (including a change in design, any component, any part, or any constituent, including
a smoke constituent, or in the content, delivery or form of nicotine, or any other additive or ingredient) of a
tobacco product where the modified product was commercially marketed in the United States after February
15, 2007.” (Pre-Existing Tobacco Product) (PTP)
Section 910(a)(2) of the FD&C Act states that premarket review is required for new tobacco products. There
are three pathways to receive marketing authorization. Substantial equivalence is one of the three pathways.
Section 910(a)(3) of the FD&C Act states that “substantial equivalence” means, with respect to the tobacco
product being compared to the predicate tobacco product, that the Secretary by order has found that the
tobacco product ‘‘(i) has the same characteristics as the predicate tobacco product; or (ii) has different
characteristics and the information submitted contains information, including clinical data if deemed necessary
by the Secretary, that demonstrates that it is not appropriate to regulate the product under this section because
the product does not raise different questions of public health.”
Section 905(j)(1)(A)(i) of the FD&C Act includes the timeframe and basis for submission of a Substantial
Equivalence Report (SE Report).

FORM FDA 3965 (11/20)

General Information

This page is deliberately blank.

Form Approved: OMB No. xxxx-xxxx
Expiration Date: xx/xx/202x
(See Burden Statement on last page.)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

TOBACCO SUBSTANTIAL EQUIVALENCE
REPORT SUBMISSION
SECTION I – APPLICANT IDENTIFICATION
Applicant Information

(The organization (manufacturer/importer) seeking a marketing authorization for a new tobacco product)
Type of Applicant (Check appropriate box)
Manufacturer (Manufacture, fabricate, assemble, process, or
label a tobacco product (see section 900(20) of the FD&C Act))

Importer (Import a finished tobacco product
for sale or distribution in the U.S.)

Date of Submission

Name of Applicant

(Provide an organization's name)
Organization Name
Company Headquarters' FDA-assigned
Facility Establishment Identifier (FEI) Number

Company Headquarters' D&B® DUNS Number

Primary Address (Street Address, P.O. Box)

Applicant Address and
Contact Information

Address 2 (Apt., Suite, Bldg., etc.)

City
Country

State, Province, or Territory

First Name

Contact Name
Prefix (e.g., Mr., Ms., Dr.)

ZIP or Postal Code

Professional Suffix (e.g., MD, Ph.D.)

Generational Suffix
(e.g., Jr., III)

Telephone (Include Country Code if applicable)

Last Name

M.I.

FAX

Position Title

Email Address

Authorized Representative Information

(Responsible official authorized to represent the applicant)
M.I.

Name of Authorized Representative First Name
(Provide a person’s name)
Prefix
(e.g., Mr., Ms., Dr.)

FORM FDA 3965 (11/20)

Generational Suffix
(e.g., Jr., III)

Professional Suffix
(e.g., MD, Ph.D.)

Page 2 of 21

Last Name
Position Title

Authorized Representative
Address and Contact Information

Primary Address (Street Address, P.O. Box)

Address 2 (Apt., Suite, Bldg., etc.)

City

State, Province, or Territory

Country

ZIP or Postal Code

Telephone (Include Country Code if applicable) FAX

Organization Name and
Address Information (Optional)

Email Address

Organization Name

Primary Address (Street Address, P.O. Box)

Select for same address as Authorized Representative

Address 2 (Apt., Suite, Bldg., etc.)

City

State, Province, or Territory

Country

ZIP or Postal Code

U.S. Agent Information

(For foreign firm where Authorized Representative does not reside in the U.S.)
Name of U.S. Agent
(Provide a person’s name)
Prefix
(e.g., Mr., Ms., Dr.)

First Name

Generational Suffix
(e.g., Jr., III)

M.I.

Professional Suffix

Position Title

(e.g., MD, Ph.D.)

Street Address (Physical Location)

U.S. Agent Address and
Contact Information
Address 2 (Apt., Suite, Bldg., etc.)

City

State, Province, or Territory
Telephone
(Include Country Code if applicable)

Country

ZIP or Postal Code
Email Address

FAX

Organization Name and
Address Information (Optional)

Organization Name

Primary Address (Street Address, P.O. Box)

Select for same address as U.S. Agent

Address 2 (Apt., Suite, Bldg., etc.)
State, Province, or Territory

FORM FDA 3965 (11/20)

Last Name

City
Country

Page 3 of 21

ZIP or Postal Code

Alternate Point of Contact
(Optional, select only one for each Alternate Point of Contact. Provide one or more persons to contact as an Alternate to
the Contacts provided elsewhere in this form.)
Applicant

Authorized Representative

Other, Regulatory

Manufacturer (Other than Applicant)

U.S. Agent

Other, Technical

First Name

Prefix (e.g., Mr., Ms., Dr.)

Professional Suffix (e.g., MD, Ph.D.)

M.I.

Generational Suffix (e.g., Jr., III)

Alternate Point of Contact Address and
Contact Information

Position Title

Primary Address (Street Address, P.O. Box)
City

Address 2 (Apt., Suite, Bldg., etc.)
State, Province, or Territory

Last Name

Country

Telephone (Include Country Code if applicable) FAX

ZIP or Postal Code
Email Address

SECTION II – TOBACCO PRODUCT INFORMATION
Unique Identification of New and Predicate Tobacco Products
You must uniquely identify both the new tobacco product(s) and the predicate tobacco product(s). Refer to
Section VII, Appendix A, to determine the appropriate table needed to document new tobacco products and
predicate tobacco products included in this application.
For a co-packaged tobacco product, complete Section II for each new tobacco product included within the copackage.
For grouped submissions, complete Section II for each tobacco product included in the bundle.

FORM FDA 3965 (11/20)

Page 4 of 21

Individual Tobacco Product
New Tobacco Product Identification
Complete for each individual new tobacco product. Refer to Section VII, Appendix B, and select the appropriate category
and subcategory. For bundled submissions or co-packaged products, select all that apply.
Check this box if your product is co-packaged, meaning multiple components are contained in the same container
closure system (e.g., a tin that contains both loose tobacco filler and rolling papers together).
Fill out Section II for all components of your co-packaged product.
New Tobacco Product Name (Brand/Sub-Brand)

Product Category and Subcategory or Product Category and Component
Roll-Your-Own Tobacco Products

Cigarettes
Filtered

Roll-Your-Own Tobacco Filler

Non-Filtered

Rolling Paper

Other (Specify below)

Filtered Cigarette Tube
Non-Filtered Cigarette Tube
Filter

Cigars

Paper Tip

Filtered, Sheet-Wrapped

Roll-Your-Own, Other (Specify below)

Unfiltered, Sheet-Wrapped
Unfiltered, Leaf-Wrapped
Cigar Tobacco Filler
Cigar Component

Smokeless Tobacco Products
Moist Snuff, Loose

Cigar, Other (Specify below)

Moist Snuff, Portioned
Snus, Loose

Electronic Nicotine Delivery Systems (Vapes)
Open E-Liquid

Snus, Portioned
Dry Snuff, Loose
Dissolvable

Closed E-Liquid

Chewing Tobacco, Loose

Open E-Cigarette

Chewing Tobacco, Portioned

Closed E-Cigarette
ENDS Component

Smokeless, Other (Specify below)

ENDS, Other (Specify below)

Waterpipe Tobacco Products
Waterpipe

Pipe Tobacco Products

Waterpipe Tobacco Filler

Pipe

Waterpipe Heat Source

Pipe Tobacco Filler

Waterpipe Component

Pipe Component
Pipe, Other (Specify below)

Waterpipe, Other (Specify below)

Other (Specify below)

Heated Tobacco Products (HTP)
Closed HTP
Open HTP
HTP Consumable
HTP Component

Other (Specify below)

HTP, Other (Specify below)

FORM FDA 3965 (11/20)

Page 5 of 21

Predicate Tobacco Product Identification
Complete for each individual predicate tobacco product. Refer to Section VII, Appendix B, and select the
appropriate category and subcategory. For bundled submissions or co-packaged products, select all that apply.
Predicate Tobacco Product Name (Brand/Sub-Brand)
Predicate Category and Subcategory or Predicate Category and Component
Cigarettes

Roll-Your-Own Tobacco Products

Filtered

Roll-Your-Own Tobacco Filler

Non-Filtered

Rolling Paper

Other (Specify below)

Filtered Cigarette Tube
Non-Filtered Cigarette Tube
Filter

Cigars

Paper Tip

Filtered, Sheet-Wrapped

Roll-Your-Own, Other (Specify below)

Unfiltered, Sheet-Wrapped
Unfiltered, Leaf-Wrapped

Smokeless Tobacco Products

Cigar Tobacco Filler
Cigar Component

Moist Snuff, Loose

Cigar, Other (Specify below)

Moist Snuff, Portioned
Snus, Loose

Electronic Nicotine Delivery Systems (Vapes)
Open E-Liquid

Snus, Portioned
Dry Snuff, Loose
Dissolvable

Closed E-Liquid

Chewing Tobacco, Loose

Open E-Cigarette

Chewing Tobacco, Portioned

Closed E-Cigarette

Smokeless, Other (Specify below)

ENDS Component
ENDS, Other (Specify below)

Waterpipe Tobacco Products
Waterpipe

Pipe Tobacco Products

Waterpipe Tobacco Filler

Pipe

Waterpipe Heat Source

Pipe Tobacco Filler

Waterpipe Component

Pipe Component

Waterpipe, Other (Specify below)

Pipe, Other (Specify below)

Heated Tobacco Products (HTP)

Other (Specify below)

Closed HTP
Open HTP
HTP Consumable
HTP Component

Other (Specify below)

HTP, Other (Specify below)

FORM FDA 3965 (11/20)

Page 6 of 21

Tobacco Product Properties
Refer to Section VII, Appendix B, to determine the specific tobacco product properties that need to be reported
based on the category and subcategory of the tobacco product. Provide data for each required property by filling in
the Tobacco Product Properties table below, and provide the target value for both the new tobacco product(s) and
predicate tobacco product.

-

New Tobacco Product

Predicate Tobacco Product

Target Value

Target Value

Name:
Property

1
2
3

4
5
6
7
8

9
10

FORM FDA 3965 (11/20)

Page 7 of 21

Tobacco Product Manufacturer Identification
Complete the subsection below for the new tobacco product if the Applicant is not the new tobacco product
manufacturer or the Applicant is an Importer of that individual new tobacco product.
Select if Applicant is an Importer
New Tobacco Product Manufacturer (If different from Applicant or Applicant is an Importer)
New Tobacco Product Name
Organization Name
Company Headquarters FDA-assigned
Facility Establishment Identifier (FEI) Number

Company Headquarters' D&B DUNS® Number

Street Address (Physical Location)
Address 2 (Apt., Suite, Bldg., etc.)
State, Province, or Territory

City
Country

ZIP or Postal Code

Complete the subsection below for the predicate tobacco product if the Applicant is not the predicate tobacco product
manufacturer or the Applicant is an Importer of that individual predicate tobacco product.

Predicate Tobacco Product Manufacturer (If different from Applicant or Applicant is an Importer)
Predicate Tobacco Product Name
Organization Name
Company Headquarters' FDA-assigned
Facility Establishment Identifier (FEI) Number

Company Headquarters' D&B DUNS® Number

Street Address (Physical Location)
Address 2 (Apt., Suite, Bldg., etc.)
State, Province, or Territory

FORM FDA 3965 (11/20)

City
Country

Page 8 of 21

ZIP or Postal Code

Basis for Predicate Tobacco Product Eligibility
Check the statement below that applies to the predicate tobacco product, and then complete all necessary information
for that statement.
The predicate tobacco product identified above was submitted for PTP review independently of this SE Report
and was determined to be a pre-existing tobacco product (PTP) and may be eligible to serve as a predicate.
Name of Product
PTP STN

Date of FDA’s PTP Determination

The predicate tobacco product was previously found to be substantially equivalent.
Name of Product
SE STN

Date of FDA’s previous SE Determination

The predicate tobacco product was not previously submitted for PTP review and was not previously
found to be substantially equivalent, but we believe it to be a pre-existing tobacco product.
Complete section B below if the first check box above is selected. Complete A and B below if the third check box above
is selected and attach all documentation needed to demonstrate that the predicate tobacco product identified above was
commercially marketed other than for test marketing in the United States as of February 15, 2007. Neither section A or
B is required if you are relying on a predicate product that was previously found to be substantially equivalent (second
check box).
A. Evidence of Commercial Marketing as of February 15, 2007
Date of Evidence

Type of Evidence (e.g., Invoice)
Evidence Identifier (e.g., Invoice Number)

Commercial Information (e.g., UPC Code, SKU Number)

Street Address (Physical Location)
Address 2 (Apt., Suite, Bldg., etc.)
State, Province, or Territory

City
Country

ZIP or Postal Code

B. Statement of Affirmation

I

(Name of responsible official)

, confirm that the predicate tobacco product
, was commercially marketed (other than

(Name of predicate tobacco product)

exclusively for test marketing) in the United States as of February 15, 2007.
Signature

FORM FDA 3965 (11/20)

Date

Page 9 of 21

SECTION III – SUBMISSION INFORMATION

For a co-packaged tobacco product, complete Section III for each new tobacco product included within the copackage.
For grouped submissions, complete Section III for each tobacco product included in the bundle.
Proposed modification(s) to the New Tobacco Product (as compared to the predicate tobacco product) (Check all
that apply)
Tobacco Blend
Container Closure System

Design
Heating Source

Material
Product Quantity

Ingredients (Specify):
Other (Specify):
Submission Summary (As described in 21 C.F.R. 1107.18(d), please summarize the submission below)

Purpose of Application (Check only one)
This SE Report is for an individual new
tobacco product.

This is a group of SE Reports containing multiple new
tobacco products with similar modifications in comparison
to one predicate tobacco product.

Type of Application (Check only one)
Same Characteristics report

Different Characteristics report

Cross-Referenced Content: Cross Reference to Tobacco Product Master Files (As applicable, enter the STN, check the
Attached Letter of Authorization box (if letter will be attached to printout or otherwise provided), and provide Master File
information.)
STN:

Attached Letter of Authorization

Information and Sections to be referenced from Master File (Enter below)

FORM FDA 3965 (11/20)

Page 10 of 21

Identify Cross-referenced Submission Type as one of the following: SE, PTP, or Tobacco Product Master File (TPMF)
New Tobacco Product Name (Provide product name if this Cross-referenced Content is relevant to a specific product)

Select if this Cross-referenced Content is relevant to all grouped products

Cross-referenced Submission Type

Cross-referenced Submission STN

Related Submissions: List the FDA submission tracking numbers (STNs) for all your previous requests for the new
tobacco products (e.g., SE, PTP, TPMF) where applicable
New Tobacco Product Name (Provide product name if this Related Submission is relevant to a specific product)
Select if this Related Submission is relevant to all grouped products
Related Submission Type

Related Submission STN

Formal Meetings Held with FDA pertaining to this tobacco product (For each meeting, as needed, enter the Submission
STN number and meeting held date.)
New Tobacco Product Name
(Provide product name if
meeting is relevant to a
specific product)

FORM FDA 3965 (11/20)

Select if this Meeting
is relevant to
all grouped products

Submission STN

Page 11 of 21

Meeting Held Date

SECTION IV – APPLICATION CONTENTS
Ensure all appropriate documents are included in this SE Report. Check all that apply.
Administrative
Cover Letter
Table of Contents
Submission Summary

Comparisons (Continued)
Composition
Materials
Ingredients, Tobacco

Basis of SE Determination

Ingredients, non-Tobacco

Unique Identification of new tobacco product(s) and
predicate tobacco product(s)

Other features
HPHCs
Other (Specify below)

Statements of Certification (Section VI)

Product Information
List of Ingredients
Information on Manufacturing Process
Health and Research (Select only one)
Health Information Summary
OR
Health Information Statement

Stability
Applicant’s basis for SE
Comparison to pre-existing tobacco product (Check
only if predicate product was previously found SE.)

Environmental Considerations (Select only one)
Environmental Assessment
OR
Claim for Categorical Exclusion

Comparisons (New vs. Predicate Tobacco Product)
Product Design
Heating Sources

FORM FDA 3965 (11/20)

Page 12 of 21

SECTION V - MANUFACTURING / PACKAGING SITES RELATING TO A SUBMISSION
(Add additional Manufacturing/Packaging sites as needed)

Company/Institution Name
Manufacturer

Contract Manufacturer

Repacker/Relabeler

Company Headquarters' FDA-assigned
Facility Establishment Identifier (FEI) Number

Company Headquarters' D&B DUNS® Number

Division Name (If applicable)

Primary Address (Street Address, P.O. Box)

City

State, Province or Territory

Telephone (Include Country Code if applicable)

Generational Suffix
(e.g., Jr., III)

Country
Email Address

FAX
First Name

Contact Name
Prefix
(e.g., Mr., Ms., Dr.)

ZIP or Postal Code

Professional Suffix
(e.g., MD, Ph.D.)

M.I.

Last Name

Position Title

SECTION VI – CERTIFICATION STATEMENTS
For the following section, state the name of the responsible official, the name of the company being represented within
this application, the individual new tobacco product(s), and the individual predicate tobacco product(s). Complete the
information for all applications.
Name of authorized representative (In this section, referred to as “the authorized representative”)
Name of company being represented (In this section, referred to as “the company”)
Name of new tobacco product(s) (In this section, referred to as “new tobacco product”)
Name of predicate tobacco product(s) (In this section, referred to as “predicate tobacco product”)
Complete the certification statement below.

I (name of responsible official)

, on behalf of (applicant)
, hereby certify that (applicant)
, will maintain all records to substantiate the
accuracy of this SE Report for the period of time required in § 1107.58 and ensure that such records remain
readily available to the FDA upon request. I certify that this information and the accompanying submission are
true and correct, that no material fact has been omitted, and that I am authorized to submit this on the applicant’s
behalf. I understand that under section 1001 of title 18 of the United States Code anyone who knowingly and
willfully makes a materially false, fictitious, or fraudulent statement to the Government of the United States is
subject to criminal penalties.

FORM FDA 3965 (11/20)

Page 13 of 21

Complete the statement below if choosing to certify that certain characteristics are identical in lieu of providing
data for each characteristic of the new and predicate tobacco products.

I (name of responsible official)

, on behalf of (name of company)
, certify that (new tobacco product name)
, has the following modification(s) as compared
to (name of predicate tobacco product)
due to
the following modification(s): (describe modification(s), e.g., change in product quantity or change in container
closure system)
.
Aside from these modifications, the characteristics of (new tobacco product name)
and (name of predicate tobacco product)
are identical. I certify that (name of
company)
understands this means there is no
other modification to the materials, ingredients, design features, heating source, or any other feature. I also certify
that (name of company)
will maintain records to
support the comparison information in § 1107.19 that substantiate the accuracy of this statement for the period of
time required in § 1107.58, and ensure that such records remain readily available to FDA upon request.

In accordance with proposed 1107.18, the following information is provided within the SE Report. Check all applicable
statements to which you attest, and then sign the statement below
General Information (1107.18(c))
Summary (1107.18(d)(1-3))
New tobacco product description (1107.18(e))
Predicate tobacco product description (1107.18(f))
Comparison information (1107.18(g))
Comparative testing information (1107.18(h))
Statement of compliance with applicable product standards (1107.18(i))
Health information summary or statement that health information is available upon request (1107.18(j))
Compliance with 21 C.F.R. part 25 (1107.18(k))
Certification (As set out in Section IV of this form, and includes certifications on record maintenance and
availability, truthfulness, and as applicable, that certain characteristics are identical.) (1107.18(l)(1) and/or (2))

By signing below, I,
are true.

, certify that statements selected above

Signature

FORM FDA 3965 (11/20)

Date

Page 14 of 21

SECTION VII – APPENDICES
Appendix A: New Tobacco Product and Predicate Tobacco Product Details
Use the tables below as examples of how to format and capture data necessary to uniquely identify products in
Section II.
Below is an example of a single new tobacco product in comparison to a single predicate tobacco product. Refer to
Appendix B for the list of properties necessary to uniquely identify a product depending upon the category and subcategory to which that product belongs.
Unique Product Identification
New Tobacco Product
Name: Product A

Predicate Tobacco Product
Name: Predicate A

Box

Box

20 Cigarettes per box

20 Cigarettes per box

100 mm

92 mm

Length

6 mm

6 mm

Ventilation

None

None

Characterizing Flavor

None

None

Additional Properties

N/A

N/A

Properties
(Inserted on form)
Package Type
Package Quantity
Diameter

Below is an example of multiple new tobacco products in comparison to a single predicate tobacco product.
Unique Product Identification
New Product 1
Name: Product A

New Product 2
Name: Product B

New Product 3
Name: Product C

Predicate
Name: Predicate A

STN: N/A

STN: N/A

STN: N/A

STN: As Assigned by FDA

Box

Box

Box

Box

20 Cigarettes per box

20 Cigarettes per box

20 Cigarettes per box

20 Cigarettes per box

100 mm

96 mm

94 mm

92 mm

Diameter

6 mm

4 mm

6 mm

6 mm

Ventilation

None

None

None

None

Characterizing Flavor

None

None

None

None

Additional Properties

N/A

N/A

N/A

N/A

Properties
(Inserted on form)
Package Type
Package Quantity
Length

FORM FDA 3965 (11/20)

Page 15 of 21

Below is an example of new tobacco products that are co-packaged together as part of one submission.
Name of Co-Package: Variety Pack A/B

Unique Product Identification
Co-Packaged Categories and
Unique Identification Properties
Category: Roll-Your-Own
Subcategory: Roll-Your-Own Tobacco Filler

Package Type

New Tobacco Product(s)

Name: Component A

Name: Predicate A

Bag

Bag

Package Quantity

100 g

150 g

Characterizing Flavor

None

None

Additional Properties

Re-sealable Bag

Re-sealable Bag

Name: Component B

Name: Predicate B

Booklet

Booklet

100 sheets

100 sheets

Length

100 mm

85 mm

Width

56 mm

56 mm

Characterizing Flavor

None

None

Additional Properties

N/A

N/A

Category: Roll-Your-Own
Subcategory: Roll-Your-Own Rolling Paper

Package Type
Package Quantity

FORM FDA 3965 (11/20)

Page 16 of 21

Appendix B: Properties Needed to Uniquely Identify the Tobacco Product, by Category and Subcategory
The following are tables outlining all necessary properties to be captured for each category and subcategory of tobacco
products. An “X” denotes a required property for that given subcategory.
Reference the charts below for completing tables necessary for Section V.

Cigarette Tobacco Products
Properties

Subcategories

Properties

All Cigarettes

Package Type

X

Product Quantity

X

Diameter

X

Length

X
X
(except non-filtered)

Ventilation
Characterizing Flavor

X

Additional Properties (if applicable)

X

Roll-Your-Own Tobacco Products
Subcategories

Properties
Tobacco
Filler

Rolling
Paper

Filtered
Cigarette
Tube

NonFiltered
Cigarette
Tube

Filter

Paper Tip

Other

Package Type

X

X

X

X

X

X

X

Product Quantity

X

X

X

X

X

X

X

Diameter

-

X

X

X

X

X

X

Properties

Length

-

Ventilation

-

Width

-

X
-

X
X

-

X
-

-

-

-

-

X

-

Characterizing Flavor

X

X

X

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

X

X

X

FORM FDA 3965 (11/20)

Page 17 of 21

Cigar
Properties

Subcategories
Component

Filtered
SheetWrapped

Unfiltered
SheetWrapped

Unfiltered
LeafWrapped

Tobacco
Filler

Other

Package Type

X

X

X

X

X

X

Product Quantity

X

X

X

X

X

X

Properties

Length

-

X

X

X

-

-

Diameter

-

X

X

X

-

-

Ventilation

-

X

-

-

Wrapper Material

-

-

Tip

-

-

-

X

X

-

-

-

-

-

Characterizing Flavor

X

X

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

X

X

Smokeless Tobacco Products
Properties
Properties

Subcategories
Loose Moist
Snuff

Portioned
Moist Snuff

Loose
Snus

Portioned
Snus

Loose Dry
Snuff

Dissolvable

Loose
Chewing

Portioned
Chewing

Other

Package Type

X

X

X

X

X

X

X

X

X

Product Quantity

X

X

X

X

X

X

X

X

X

Portion Count

-

X

Portion Length

-

X

Portion Width

-

X

Portion Mass

-

X

Portion Thickness

-

X

X

-

-

X

-

X

-

-

X

-

X

-

X

-

X

X

-

X

X

-

X

-

X

-

X

-

X

-

X

-

-

Characterizing
Flavor

X

X

X

X

X

X

X

X

X

Additional
Properties (if
applicable)

X

X

X

X

X

X

X

X

X

FORM FDA 3965 (11/20)

Page 18 of 21

Electronic Nicotine Delivery Systems (Vapes)
Properties
Properties

Subcategories
Component

Open ELiquid

Closed ELiquid

Open ECigarette

Closed ECigarette

Other

Package Type

X

X

X

X

X

X

Product Quantity

X

X

X

X

X

X

Length

-

-

-

X

X

-

Diameter

-

-

-

X

X

-

E-Liquid Volume

-

X

X

X

X

-

Nicotine Concentration

-

X

X

-

X

-

PG/VG Ratio

-

X

X

-

X

-

Battery Capacity

-

-

-

X

X

-

Wattage

-

-

-

X

X

-

Characterizing Flavor

X

X

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

X

X

Heated Tobacco Products (HTP)
Properties

Subcategories

Properties

Component

Closed HTP

Open HTP

Consumable

Other

Package Type

X

X

X

X

X

Product Quantity

X

X

X

X

X

Length

-

X

X

X

-

Diameter

-

X

X

X

-

Ventilation

-

X

-

Wattage

-

X

X

-

-

Battery Capacity

-

X

X

-

-

-

-

Characterizing Flavor

X

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

X

FORM FDA 3965 (11/20)

Page 19 of 21

Pipe Tobacco Products
Properties

Subcategories

Properties

Component

Pipe

Tobacco
Filler

Other

Package Type

X

X

X

X

Product Quantity

X

X

X

X

Tobacco Cut Style

-

Length

-

-

X

-

Diameter

-

X

X

-

-

Characterizing Flavor

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

Waterpipe Tobacco Products
Properties
Properties

Subcategories
Component

Waterpipe

Heat Source

Tobacco
Filler

Other

Package Type

X

X

X

X

X

Product Quantity

X

X

X

X

X

Height

-

X

-

-

-

Width

-

X

-

-

-

Diameter

-

X

-

-

-

Portion Count

-

-

X

-

-

Portion Length

-

-

X

-

-

Portion Width

-

-

X

-

-

Portion Mass

-

-

X

-

-

-

X

Portion Thickness

-

Number of Hoses

-

Source(s) of Energy

-

X
-

X

-

-

-

-

-

Characterizing Flavor

X

X

X

X

X

Additional Properties (if applicable)

X

X

X

X

X

FORM FDA 3965 (11/20)

Page 20 of 21

Other Products
Properties

Subcategory

Properties

Other

Package Type

X

Product Quantity

X

Characterizing Flavor

X

Additional Properties (if applicable)

X

This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 45 minutes per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Operations
Paperwork Reduction Act (PRA) Staff
[email protected]
“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number.”

FORM FDA 3965 (11/20)

Page 21 of 21


File Typeapplication/pdf
File TitleTobacco Substantial Equivalence Report Submission Form
SubjectTobacco Substantial Equivalence Report, Amendment, General Correspondence, Submission, Application, FDA, Food and Drug Administr
AuthorDepartment of Health and Human Services
File Modified2020-12-17
File Created2020-11-19

© 2024 OMB.report | Privacy Policy